Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients

Published:2022-04-11 Issue:20 Volume:41 Page:2798-2810
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Bramhecha Yogesh M.,Guérard Karl-Philippe,Audet-Walsh Étienne^ORCID,Rouzbeh Shaghayegh,Kassem Ola,Pernet Erwan,Scarlata Eleonora,Hamel Lucie,Brimo Fadi,Divangahi Maziar,Aprikian Armen G.,Chevalier Simone,Giguère Vincent^ORCID,Lapointe Jacques^ORCID

Funder

U.S. Department of Defense

Prostate Cancer Canada

Fonds de Recherche du Québec - Santé

Gouvernement du Canada | Canadian Institutes of Health Research

Faculty of Medicine, McGill University

100 Days Across Canada Urology Studentship Program on Prostate Cancer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02276-z.pdf

Reference55 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: a cancer journal for clinicians. 2020;70:7–30.

2. Yuan X, Balk SP. Mechanisms mediating androgen receptor reactivation after castration. Urologic Oncol. 2009;27:36–41.

3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–74.

4. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009;23:537–48.

5. Liu Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis. 2006;9:230–4.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD);Frontiers in Molecular Medicine;2024-01-08

2. New insights into lipid metabolism and prostate cancer (Review);International Journal of Oncology;2023-05-17

3. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective;Cell Death Discovery;2023-04-15

4. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer;International Journal of Molecular Sciences;2023-01-04

5. Reperfusion after hypoxia-ischemia exacerbates brain injury with compensatory activation of the anti- ferroptosis system: based on a novel rat model;Neural Regeneration Research;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3